The global multi-omics cancer database
IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database.
Thus, providing new insights into the biology of cancer and enabling new discoveries in the postgenomic era.
IndivuType offers a powerful and easy-to-use database that supports the identification and validation of new molecular drug targets and biomarkers, patient stratification and cohort design for clinical trials, as well as multiple molecular aspects in basic and clinical research.
Research beyond genomics
Thanks to the vast array of standardized and fully comparable biospecimens, together with additional clinical information from a comprehensive spectrum of ethnicities across the globe, we are able to implement breakthrough techniques to generate complex data – including whole genome sequencing, transcriptomics, proteomics, phospho-proteomics, and immunohistochemistry.
Integrated IT solutions offer you a variety of statistical, bioinformatics, artificial intelligence, and other tools to analyze the data in the way you require, providing an unprecedented view of the appearance, profile, treatment, and outcome of cancer.
Comprehensive data visualization Statistical, bioinfomatics and artifical intelligence tools for:
- Clinical evaluation
- Biomarker identification and validation
- Target identification and validation
Please don’t hesitate to contact us; we will identify your optimal licensing model and provide you with access to the data and analytical tools that match your specific needs.
Call us now at +49-40-413-3830
Send an e-mail to: firstname.lastname@example.org